Structure

Physi-Chem Properties

Molecular Weight:  432.13
Volume:  389.152
LogP:  -1.294
LogD:  -0.858
LogS:  -2.036
# Rotatable Bonds:  7
TPSA:  195.6
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.214
Synthetic Accessibility Score:  4.507
Fsp3:  0.611
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.562
MDCK Permeability:  2.9770057153655216e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.98
Human Intestinal Absorption (HIA):  0.94
20% Bioavailability (F20%):  0.82
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.207
Plasma Protein Binding (PPB):  44.03428649902344%
Volume Distribution (VD):  0.408
Pgp-substrate:  53.97146224975586%

ADMET: Metabolism

CYP1A2-inhibitor:  0.03
CYP1A2-substrate:  0.033
CYP2C19-inhibitor:  0.012
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.051
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.119
CYP3A4-inhibitor:  0.017
CYP3A4-substrate:  0.015

ADMET: Excretion

Clearance (CL):  1.327
Half-life (T1/2):  0.778

ADMET: Toxicity

hERG Blockers:  0.208
Human Hepatotoxicity (H-HT):  0.043
Drug-inuced Liver Injury (DILI):  0.116
AMES Toxicity:  0.416
Rat Oral Acute Toxicity:  0.012
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.493
Carcinogencity:  0.044
Eye Corrosion:  0.003
Eye Irritation:  0.092
Respiratory Toxicity:  0.062

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC289438

Natural Product ID:  NPC289438
Common Name*:   Bretschneideroside B
IUPAC Name:   4-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxybenzaldehyde
Synonyms:  
Standard InCHIKey:  HNPKQZLEUUJVIJ-FQXXIRCGSA-N
Standard InCHI:  InChI=1S/C18H24O12/c19-4-8-1-2-10(9(21)3-8)29-16-14(24)13(23)12(22)11(30-16)5-27-17-15(25)18(26,6-20)7-28-17/h1-4,11-17,20-26H,5-7H2/t11-,12-,13+,14-,15+,16-,17-,18-/m1/s1
SMILES:  c1cc(c(cc1C=O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]2[C@@H]([C@@](CO)(CO2)O)O)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1223634
PubChem CID:   46938555
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1813 Bretschneidera sinensis Species Akaniaceae Eukaryota stems Jiujiang, Jiangxi Province, China 2008-AUG PMID[20722446]
NPO1813 Bretschneidera sinensis Species Akaniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO1813 Bretschneidera sinensis Species Akaniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1813 Bretschneidera sinensis Species Akaniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT937 Cell Line NCI-H446 Homo sapiens IC50 > 100.0 ug.mL-1 PMID[523672]
NPT116 Cell Line HL-60 Homo sapiens IC50 > 100.0 ug.mL-1 PMID[523672]
NPT393 Cell Line HCT-116 Homo sapiens IC50 > 100.0 ug.mL-1 PMID[523672]
NPT937 Cell Line NCI-H446 Homo sapiens GI = 38.43 % PMID[523672]
NPT116 Cell Line HL-60 Homo sapiens GI = 7.25 % PMID[523672]
NPT393 Cell Line HCT-116 Homo sapiens GI = 0.0 % PMID[523672]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100.0 ug.mL-1 PMID[523672]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 0.0 % PMID[523672]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC289438 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9724 High Similarity NPC227980
0.9324 High Similarity NPC205054
0.9205 High Similarity NPC194095
0.9205 High Similarity NPC191046
0.9205 High Similarity NPC327032
0.9184 High Similarity NPC473867
0.915 High Similarity NPC226759
0.9085 High Similarity NPC471405
0.9073 High Similarity NPC134905
0.9073 High Similarity NPC36130
0.9026 High Similarity NPC133984
0.902 High Similarity NPC10205
0.9013 High Similarity NPC310661
0.9013 High Similarity NPC157898
0.9013 High Similarity NPC105827
0.8968 High Similarity NPC289811
0.8968 High Similarity NPC160780
0.8926 High Similarity NPC9370
0.8926 High Similarity NPC287495
0.891 High Similarity NPC239966
0.891 High Similarity NPC203020
0.8903 High Similarity NPC1913
0.8889 High Similarity NPC137813
0.8889 High Similarity NPC212729
0.8874 High Similarity NPC111785
0.8854 High Similarity NPC472859
0.8854 High Similarity NPC311803
0.8854 High Similarity NPC25389
0.8851 High Similarity NPC242756
0.8846 High Similarity NPC74319
0.8846 High Similarity NPC287872
0.882 High Similarity NPC212748
0.8808 High Similarity NPC472969
0.8797 High Similarity NPC33298
0.8797 High Similarity NPC41009
0.8797 High Similarity NPC285108
0.8797 High Similarity NPC476011
0.879 High Similarity NPC119125
0.879 High Similarity NPC166277
0.879 High Similarity NPC289346
0.8782 High Similarity NPC472860
0.8759 High Similarity NPC55040
0.875 High Similarity NPC98809
0.875 High Similarity NPC476394
0.8742 High Similarity NPC88043
0.8707 High Similarity NPC100389
0.8707 High Similarity NPC226005
0.8704 High Similarity NPC72249
0.8699 High Similarity NPC186418
0.8688 High Similarity NPC180586
0.8688 High Similarity NPC165720
0.8679 High Similarity NPC4013
0.8679 High Similarity NPC148273
0.8679 High Similarity NPC90905
0.8659 High Similarity NPC84482
0.8659 High Similarity NPC169645
0.8654 High Similarity NPC180901
0.8654 High Similarity NPC300757
0.865 High Similarity NPC235575
0.8649 High Similarity NPC202700
0.8645 High Similarity NPC44730
0.8634 High Similarity NPC130730
0.8634 High Similarity NPC301910
0.8627 High Similarity NPC478242
0.8627 High Similarity NPC75945
0.8609 High Similarity NPC108455
0.8598 High Similarity NPC316539
0.8591 High Similarity NPC79908
0.8591 High Similarity NPC80098
0.8581 High Similarity NPC75695
0.8581 High Similarity NPC203664
0.858 High Similarity NPC149244
0.858 High Similarity NPC45400
0.858 High Similarity NPC48640
0.858 High Similarity NPC116745
0.8571 High Similarity NPC37468
0.8571 High Similarity NPC294470
0.8571 High Similarity NPC157554
0.8571 High Similarity NPC104172
0.8571 High Similarity NPC88886
0.8571 High Similarity NPC475738
0.8562 High Similarity NPC22324
0.8553 High Similarity NPC291153
0.8553 High Similarity NPC474936
0.8552 High Similarity NPC252833
0.8544 High Similarity NPC286919
0.8544 High Similarity NPC475663
0.8543 High Similarity NPC110063
0.8543 High Similarity NPC229036
0.8543 High Similarity NPC473090
0.8537 High Similarity NPC261254
0.8533 High Similarity NPC157816
0.8528 High Similarity NPC197708
0.8528 High Similarity NPC658
0.8528 High Similarity NPC229687
0.8526 High Similarity NPC183536
0.8526 High Similarity NPC245615
0.8526 High Similarity NPC299706
0.8526 High Similarity NPC131121
0.8526 High Similarity NPC61604
0.8526 High Similarity NPC34965
0.8526 High Similarity NPC115466
0.8523 High Similarity NPC210478
0.8519 High Similarity NPC254306
0.8519 High Similarity NPC282551
0.8516 High Similarity NPC140151
0.8509 High Similarity NPC168822
0.8509 High Similarity NPC94777
0.8509 High Similarity NPC191306
0.8509 High Similarity NPC227297
0.8509 High Similarity NPC270335
0.8506 High Similarity NPC92117
0.8494 Intermediate Similarity NPC473713
0.8493 Intermediate Similarity NPC6836
0.8493 Intermediate Similarity NPC25821
0.8491 Intermediate Similarity NPC76211
0.8491 Intermediate Similarity NPC469384
0.8481 Intermediate Similarity NPC163635
0.8477 Intermediate Similarity NPC478239
0.8476 Intermediate Similarity NPC471416
0.8476 Intermediate Similarity NPC149011
0.8476 Intermediate Similarity NPC204937
0.8476 Intermediate Similarity NPC34287
0.8467 Intermediate Similarity NPC326065
0.8467 Intermediate Similarity NPC186406
0.8466 Intermediate Similarity NPC45618
0.8466 Intermediate Similarity NPC229729
0.8466 Intermediate Similarity NPC146792
0.8466 Intermediate Similarity NPC58716
0.8462 Intermediate Similarity NPC99772
0.8457 Intermediate Similarity NPC311830
0.8457 Intermediate Similarity NPC22832
0.8456 Intermediate Similarity NPC220942
0.8452 Intermediate Similarity NPC473091
0.8447 Intermediate Similarity NPC77660
0.8447 Intermediate Similarity NPC206815
0.8447 Intermediate Similarity NPC300537
0.8447 Intermediate Similarity NPC127782
0.8447 Intermediate Similarity NPC246024
0.8447 Intermediate Similarity NPC189142
0.8446 Intermediate Similarity NPC470572
0.8442 Intermediate Similarity NPC116229
0.8442 Intermediate Similarity NPC248257
0.8442 Intermediate Similarity NPC120621
0.8438 Intermediate Similarity NPC138993
0.8438 Intermediate Similarity NPC44507
0.8435 Intermediate Similarity NPC144662
0.8435 Intermediate Similarity NPC45404
0.8435 Intermediate Similarity NPC470881
0.8434 Intermediate Similarity NPC469354
0.8434 Intermediate Similarity NPC469438
0.8434 Intermediate Similarity NPC472607
0.8431 Intermediate Similarity NPC474044
0.8431 Intermediate Similarity NPC98356
0.8428 Intermediate Similarity NPC40920
0.8428 Intermediate Similarity NPC104275
0.8428 Intermediate Similarity NPC4747
0.8428 Intermediate Similarity NPC223335
0.8425 Intermediate Similarity NPC473924
0.8424 Intermediate Similarity NPC205076
0.8424 Intermediate Similarity NPC48773
0.8424 Intermediate Similarity NPC245452
0.8424 Intermediate Similarity NPC307518
0.8424 Intermediate Similarity NPC102851
0.8424 Intermediate Similarity NPC5786
0.8421 Intermediate Similarity NPC232228
0.8421 Intermediate Similarity NPC297342
0.8415 Intermediate Similarity NPC469931
0.8415 Intermediate Similarity NPC226294
0.8415 Intermediate Similarity NPC45638
0.8415 Intermediate Similarity NPC475942
0.8415 Intermediate Similarity NPC58053
0.8415 Intermediate Similarity NPC186807
0.8415 Intermediate Similarity NPC201292
0.8415 Intermediate Similarity NPC21956
0.8415 Intermediate Similarity NPC471457
0.8415 Intermediate Similarity NPC170675
0.8415 Intermediate Similarity NPC93337
0.8415 Intermediate Similarity NPC476771
0.8415 Intermediate Similarity NPC95421
0.8415 Intermediate Similarity NPC198125
0.8415 Intermediate Similarity NPC105025
0.8415 Intermediate Similarity NPC112755
0.8414 Intermediate Similarity NPC298268
0.8408 Intermediate Similarity NPC215811
0.8405 Intermediate Similarity NPC255615
0.8405 Intermediate Similarity NPC197285
0.8405 Intermediate Similarity NPC236934
0.8405 Intermediate Similarity NPC67037
0.8405 Intermediate Similarity NPC5778
0.8405 Intermediate Similarity NPC99957
0.8405 Intermediate Similarity NPC21100
0.8405 Intermediate Similarity NPC181616
0.8397 Intermediate Similarity NPC243891
0.8395 Intermediate Similarity NPC284960
0.8395 Intermediate Similarity NPC243930
0.8395 Intermediate Similarity NPC470178
0.8395 Intermediate Similarity NPC100425
0.8395 Intermediate Similarity NPC19709
0.8395 Intermediate Similarity NPC88023

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC289438 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8696 High Similarity NPD3818 Discontinued
0.8373 Intermediate Similarity NPD7685 Pre-registration
0.8303 Intermediate Similarity NPD7054 Approved
0.8253 Intermediate Similarity NPD7074 Phase 3
0.8253 Intermediate Similarity NPD7472 Approved
0.8214 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8207 Intermediate Similarity NPD9494 Approved
0.8137 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD6797 Phase 2
0.8086 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD7251 Discontinued
0.8038 Intermediate Similarity NPD1653 Approved
0.8025 Intermediate Similarity NPD3882 Suspended
0.8 Intermediate Similarity NPD7808 Phase 3
0.795 Intermediate Similarity NPD1934 Approved
0.7941 Intermediate Similarity NPD6559 Discontinued
0.7898 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD6190 Approved
0.7798 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD6166 Phase 2
0.7798 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD2801 Approved
0.7791 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD230 Phase 1
0.7759 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD7266 Discontinued
0.7707 Intermediate Similarity NPD4628 Phase 3
0.7674 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD6234 Discontinued
0.7602 Intermediate Similarity NPD7228 Approved
0.7576 Intermediate Similarity NPD1465 Phase 2
0.7562 Intermediate Similarity NPD1511 Approved
0.7558 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD3817 Phase 2
0.7515 Intermediate Similarity NPD7199 Phase 2
0.7515 Intermediate Similarity NPD37 Approved
0.75 Intermediate Similarity NPD4380 Phase 2
0.7485 Intermediate Similarity NPD4965 Approved
0.7485 Intermediate Similarity NPD4967 Phase 2
0.7485 Intermediate Similarity NPD4966 Approved
0.7469 Intermediate Similarity NPD1512 Approved
0.7457 Intermediate Similarity NPD5844 Phase 1
0.7456 Intermediate Similarity NPD5494 Approved
0.745 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD1091 Approved
0.7419 Intermediate Similarity NPD447 Suspended
0.7347 Intermediate Similarity NPD1357 Approved
0.7345 Intermediate Similarity NPD8313 Approved
0.7345 Intermediate Similarity NPD8312 Approved
0.7337 Intermediate Similarity NPD7075 Discontinued
0.7326 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD3751 Discontinued
0.7273 Intermediate Similarity NPD3027 Phase 3
0.7262 Intermediate Similarity NPD8455 Phase 2
0.7253 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD1549 Phase 2
0.7244 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD1613 Approved
0.7238 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD8434 Phase 2
0.7219 Intermediate Similarity NPD5353 Approved
0.7219 Intermediate Similarity NPD5402 Approved
0.7209 Intermediate Similarity NPD1247 Approved
0.72 Intermediate Similarity NPD3705 Approved
0.7197 Intermediate Similarity NPD1933 Approved
0.7193 Intermediate Similarity NPD919 Approved
0.7188 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6232 Discontinued
0.7168 Intermediate Similarity NPD3787 Discontinued
0.7162 Intermediate Similarity NPD9545 Approved
0.716 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD9269 Phase 2
0.7143 Intermediate Similarity NPD6386 Approved
0.7143 Intermediate Similarity NPD6385 Approved
0.7135 Intermediate Similarity NPD7240 Approved
0.7134 Intermediate Similarity NPD6799 Approved
0.7125 Intermediate Similarity NPD1551 Phase 2
0.7124 Intermediate Similarity NPD1049 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6801 Discontinued
0.7099 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7819 Suspended
0.7055 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD7473 Discontinued
0.7029 Intermediate Similarity NPD3926 Phase 2
0.7015 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD8127 Discontinued
0.7006 Intermediate Similarity NPD3764 Approved
0.7006 Intermediate Similarity NPD5403 Approved
0.6994 Remote Similarity NPD6674 Discontinued
0.6988 Remote Similarity NPD2532 Approved
0.6988 Remote Similarity NPD2533 Approved
0.6988 Remote Similarity NPD2534 Approved
0.6988 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6987 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6984 Remote Similarity NPD6781 Approved
0.6984 Remote Similarity NPD6777 Approved
0.6984 Remote Similarity NPD6779 Approved
0.6984 Remote Similarity NPD6776 Approved
0.6984 Remote Similarity NPD6782 Approved
0.6984 Remote Similarity NPD6780 Approved
0.6984 Remote Similarity NPD6778 Approved
0.698 Remote Similarity NPD5536 Phase 2
0.6957 Remote Similarity NPD1510 Phase 2
0.6951 Remote Similarity NPD4110 Phase 3
0.6951 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6944 Remote Similarity NPD7039 Approved
0.6944 Remote Similarity NPD7038 Approved
0.6941 Remote Similarity NPD7411 Suspended
0.6936 Remote Similarity NPD3749 Approved
0.6933 Remote Similarity NPD2424 Discontinued
0.6933 Remote Similarity NPD970 Clinical (unspecified phase)
0.6923 Remote Similarity NPD824 Approved
0.6923 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6919 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6918 Remote Similarity NPD943 Approved
0.6914 Remote Similarity NPD2796 Approved
0.6914 Remote Similarity NPD2935 Discontinued
0.691 Remote Similarity NPD2163 Approved
0.6905 Remote Similarity NPD920 Approved
0.6899 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6887 Remote Similarity NPD9268 Approved
0.6886 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6886 Remote Similarity NPD5401 Approved
0.6886 Remote Similarity NPD642 Clinical (unspecified phase)
0.6882 Remote Similarity NPD7028 Phase 2
0.6882 Remote Similarity NPD6599 Discontinued
0.6875 Remote Similarity NPD7435 Discontinued
0.6871 Remote Similarity NPD2344 Approved
0.6867 Remote Similarity NPD5058 Phase 3
0.686 Remote Similarity NPD5761 Phase 2
0.686 Remote Similarity NPD5760 Phase 2
0.6855 Remote Similarity NPD6233 Phase 2
0.6852 Remote Similarity NPD7033 Discontinued
0.6848 Remote Similarity NPD3750 Approved
0.6842 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6836 Remote Similarity NPD5242 Approved
0.6832 Remote Similarity NPD6653 Approved
0.6826 Remote Similarity NPD4357 Discontinued
0.6824 Remote Similarity NPD7458 Discontinued
0.6824 Remote Similarity NPD3455 Phase 2
0.6818 Remote Similarity NPD1608 Approved
0.6818 Remote Similarity NPD6959 Discontinued
0.6813 Remote Similarity NPD1240 Approved
0.6803 Remote Similarity NPD228 Approved
0.6802 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6802 Remote Similarity NPD7783 Phase 2
0.6795 Remote Similarity NPD1203 Approved
0.679 Remote Similarity NPD7097 Phase 1
0.6788 Remote Similarity NPD7698 Approved
0.6788 Remote Similarity NPD7696 Phase 3
0.6788 Remote Similarity NPD2800 Approved
0.6788 Remote Similarity NPD7697 Approved
0.6788 Remote Similarity NPD7680 Approved
0.6786 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6786 Remote Similarity NPD3146 Approved
0.6784 Remote Similarity NPD1337 Clinical (unspecified phase)
0.6774 Remote Similarity NPD6377 Clinical (unspecified phase)
0.677 Remote Similarity NPD6355 Discontinued
0.6769 Remote Similarity NPD7584 Approved
0.6768 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6766 Remote Similarity NPD643 Clinical (unspecified phase)
0.6763 Remote Similarity NPD2978 Approved
0.6763 Remote Similarity NPD1006 Clinical (unspecified phase)
0.6763 Remote Similarity NPD2977 Approved
0.6753 Remote Similarity NPD7871 Phase 2
0.6753 Remote Similarity NPD7870 Phase 2
0.6752 Remote Similarity NPD5647 Approved
0.6748 Remote Similarity NPD651 Clinical (unspecified phase)
0.6747 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6746 Remote Similarity NPD6273 Approved
0.6739 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6736 Remote Similarity NPD6823 Phase 2
0.6735 Remote Similarity NPD7701 Phase 2
0.6735 Remote Similarity NPD7585 Approved
0.6733 Remote Similarity NPD4665 Approved
0.6733 Remote Similarity NPD4111 Phase 1
0.6728 Remote Similarity NPD2492 Phase 1
0.6728 Remote Similarity NPD1607 Approved
0.6725 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6725 Remote Similarity NPD3226 Approved
0.672 Remote Similarity NPD6534 Approved
0.672 Remote Similarity NPD3473 Clinical (unspecified phase)
0.672 Remote Similarity NPD6535 Approved
0.6718 Remote Similarity NPD7999 Approved
0.6711 Remote Similarity NPD1241 Discontinued
0.671 Remote Similarity NPD9717 Approved
0.6709 Remote Similarity NPD2861 Phase 2
0.6708 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6707 Remote Similarity NPD2309 Approved
0.6707 Remote Similarity NPD3887 Approved
0.6707 Remote Similarity NPD2354 Approved
0.6704 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6701 Remote Similarity NPD8151 Discontinued
0.6687 Remote Similarity NPD6798 Discontinued
0.6684 Remote Similarity NPD7583 Approved
0.6667 Remote Similarity NPD1375 Discontinued
0.6667 Remote Similarity NPD1899 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data